Newsletters
Oral Nano-Delivery of a Gut Microbial Metabolite Enhances T Cell Stemness for Cancer Immunotherapy
[Nature Nanotechnology] Through an in vitro screening of gut microbial metabolites, scientists identified 3,4-dihydroxybenzoic acid that improved adoptive T cell therapy and enhanced CD8+ T cell stemness by suppressing glycolysis and regulating the Akt-mTORC1-Myc pathway.
Cluster of Differentiation 36-Engineered Photosynthetic Cyanobacteria Enable Immunometabolic Reprogramming in Triple-Negative Breast Cancer
[Acta Biomaterialia] Investigators reported a living biohybrid strategy that simultaneously regulates lipid metabolism and oxygen availability to reprogram the TNBC microenvironment.
Transcriptomic Profiling of Mouse Mammary Tumors Enables Prognostic and Predictive Biomarker Discovery for Human Breast Cancer
[Cancer Research] Scientists generated an extensive mouse model dataset comprised of 26 immunocompetent mammary tumor models spanning diverse genetic backgrounds, epithelial–mesenchymal states, the basal–luminal axis, and distinct immune microenvironments.
The Germ Layer: Foundation of Mesenchymal Stem Cell Therapeutic Destiny
[Cell Death & Disease] The authors provide a systematic comparison of stem cells originating from the surface ectoderm, neural crest ectoderm, and mesoderm, highlighting their distinct molecular signatures, functional properties, and therapeutic utility.
Mesenchymal Stem Cells Protect against Diabetic Nephropathy through Gut Microbiota-Butyrate-Mediated Inhibition of Neutrophil Extracellular Traps
[Nutrition & Diabetes] Administration of MSCs, as well as fecal microbiota transplantation from MSC-treated donors, significantly ameliorated renal injury and suppressed neutrophil extracellular trap formation in diabetic nephropathy rats.
Mesenchymal Stromal Cells Immunosuppress Osteoarthritis Synovial Fluid Modulated Monocytes via IL-6 and CCL2
[Cell Death & Disease] Investigators hypothesized that MSC soluble factors, particularly interleukin-6 (IL-6) and C-C motif chemokine ligand (CCL2) modulate monocytes in knee osteoarthritis environment.
Cysteine Preconditioning Improves Post-Freeze-Thaw Proliferative Capacity of Human Synovial Mesenchymal Stem Cells
[Scientific Reports] Researchers examined whether cysteine preconditioning improves post-freeze–thaw proliferation and whether glutathione responsiveness is associated with donor-dependent variability.
Procr+ Endothelial Progenitor Cells Govern Hematopoiesis through Fine-Tuning Mesenchymal Stem Cell Niche Signals
[Blood] Investigators showed that protein C receptor–positive (Procr+) endothelial progenitor cells sustain vascular integrity and govern MSC-dependent hematopoietic stem cell maintenance, offering targeted clinical strategies for niche regeneration.
Engineering Injectable Alginate Hydrogels for Mesenchymal Stem Cell Delivery: Comparative Evaluation of Ionic Crosslinking Strategies and Early In Vitro Outcomes
[Biomedical Materials] Scientists investigated how three ionic crosslinking strategies-internal gelation, external gelation, and combined internal-external gelation-govern the material performance of alginate hydrogels engineered for human adipose-derived MSC delivery.
Single-Cell Profiling Uncovers a Rare Mesenchymal-Like Urothelial State Associated with Sarcomatoid Bladder Cancer
[Cell Death & Disease] Researchers identified and characterized a rare population of mesenchymal-like urothelial cells, termed M-cells, representing approximately 1–3% of urothelial cells. M-cells co-express epithelial markers with mesenchymal and stemness genes and engage stem cell-associated transcriptional regulators.
Fannin Receives CDMRP and Faris Foundation Grants to Advance Targeted RapDC Therapy for Ewing Sarcoma
[Fannin Partners, LLC (PR Newswire)] Fannin Partners, LLC today announced two new grants from the Congressionally Directed Medical Research Programs (CDMRP) and the Faris Foundation to advance development of a targeted Raptamer-Drug Conjugate (RapDC) therapy for Ewing sarcoma
Engineered Macrophages with IL-10-TLR9 Signal Switch Receptors for Reprogramming Tumor Microenvironment and Enhancing Antitumor Immunity
[Experimental & Molecular Medicine] Investigators developed a CAR-like signal-switching receptor-macrophage that recognizes IL-10, a major immunosuppressive cytokine enriched in solid tumors, and converts this inhibitory signal into a pro-inflammatory activation through the Toll-like receptor 9 (TLR9) intracellular signaling pathway.

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
